NO164415C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.Info
- Publication number
- NO164415C NO164415C NO841691A NO841691A NO164415C NO 164415 C NO164415 C NO 164415C NO 841691 A NO841691 A NO 841691A NO 841691 A NO841691 A NO 841691A NO 164415 C NO164415 C NO 164415C
- Authority
- NO
- Norway
- Prior art keywords
- pyridinones
- acyl
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/490,081 US4568751A (en) | 1983-04-29 | 1983-04-29 | 5-Acyl-2-(1H)-pyridinones |
Publications (3)
Publication Number | Publication Date |
---|---|
NO841691L NO841691L (no) | 1984-10-30 |
NO164415B NO164415B (no) | 1990-06-25 |
NO164415C true NO164415C (no) | 1990-10-03 |
Family
ID=23946554
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO841690A NO164416C (no) | 1983-04-29 | 1984-04-27 | Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. |
NO841691A NO164415C (no) | 1983-04-29 | 1984-04-27 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO841690A NO164416C (no) | 1983-04-29 | 1984-04-27 | Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4568751A (no) |
EP (2) | EP0124090B1 (no) |
JP (2) | JPS59206356A (no) |
KR (2) | KR900005011B1 (no) |
AR (1) | AR240313A1 (no) |
AT (2) | ATE26262T1 (no) |
AU (2) | AU571219B2 (no) |
CA (2) | CA1256880A (no) |
DD (1) | DD223444A5 (no) |
DE (2) | DE3462503D1 (no) |
DK (2) | DK159425C (no) |
ES (2) | ES531910A0 (no) |
GR (2) | GR81967B (no) |
HU (2) | HU191928B (no) |
IE (2) | IE57273B1 (no) |
IL (2) | IL71649A (no) |
NO (2) | NO164416C (no) |
NZ (2) | NZ207961A (no) |
PH (1) | PH20256A (no) |
PT (2) | PT78493B (no) |
SU (1) | SU1299505A3 (no) |
ZA (2) | ZA843034B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118696A (en) * | 1983-04-29 | 1992-06-02 | Merrell Dow Pharmaceuticals Inc. | 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure |
US4731371A (en) * | 1984-03-29 | 1988-03-15 | Merrell Dow Pharmaceuticals Inc. | Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents |
US5428045A (en) * | 1983-04-29 | 1995-06-27 | Merrell Dow Pharmaceuticals Inc. | 5-acyl-2-(1H)-pyridinoes |
US4992452A (en) * | 1983-04-29 | 1991-02-12 | Merrell Dow Pharmaceuticals Inc. | Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure |
US4853395A (en) * | 1983-04-29 | 1989-08-01 | Merrell Dow Pharmaceuticals Inc. | Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties |
US4568751A (en) * | 1983-04-29 | 1986-02-04 | Merrell Dow Pharmaceuticals Inc. | 5-Acyl-2-(1H)-pyridinones |
US5212314A (en) * | 1983-11-03 | 1993-05-18 | Merrell Dow Pharmaceuticals Inc. | Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
US4732982A (en) * | 1983-11-03 | 1988-03-22 | Merrell Dow Pharmaceuticals Inc. | Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
US4657919A (en) * | 1984-08-03 | 1987-04-14 | E. I. Du Pont De Nemours & Co. | Pyridone esters as inotropic agents |
US4650806A (en) * | 1985-01-14 | 1987-03-17 | Sterling Drug Inc. | Cardiotonic 5-(heterylcarbonyl)-pyridones |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2531035A1 (de) * | 1975-07-11 | 1977-01-27 | Basf Ag | Verfahren zur herstellung von 5-cyanpyridonen-(6) |
US4072746A (en) * | 1975-10-14 | 1978-02-07 | Sterling Drug Inc. | 3-Amino-5-(pyridinyl)-2(1H)-pyridinones |
GB1596887A (en) * | 1977-07-15 | 1981-09-03 | Rohm & Haas | 2-pyridone derivatives and their use as plant growth regulators |
DE3005069A1 (de) * | 1980-02-11 | 1981-08-20 | Cassella Ag, 6000 Frankfurt | Pyridonderivate, ihre herstellung und ihre verwendung |
DE3106460A1 (de) * | 1980-03-03 | 1982-01-28 | Sandoz-Patent-GmbH, 7850 Lörrach | 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen |
US4524149A (en) * | 1982-03-15 | 1985-06-18 | Sterling Drug Inc. | 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use |
US4412077A (en) * | 1982-03-15 | 1983-10-25 | Sterling Drug Inc. | Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone |
US4568751A (en) * | 1983-04-29 | 1986-02-04 | Merrell Dow Pharmaceuticals Inc. | 5-Acyl-2-(1H)-pyridinones |
DE3406329A1 (de) * | 1984-02-22 | 1985-08-22 | Merck Patent Gmbh, 6100 Darmstadt | Pyridone |
-
1983
- 1983-04-29 US US06/490,081 patent/US4568751A/en not_active Expired - Lifetime
-
1984
- 1984-04-19 AU AU27141/84A patent/AU571219B2/en not_active Ceased
- 1984-04-19 AU AU27131/84A patent/AU557543B2/en not_active Ceased
- 1984-04-24 ZA ZA843034A patent/ZA843034B/xx unknown
- 1984-04-24 AR AR296404A patent/AR240313A1/es active
- 1984-04-24 ZA ZA843033A patent/ZA843033B/xx unknown
- 1984-04-25 ES ES531910A patent/ES531910A0/es active Granted
- 1984-04-25 ES ES531911A patent/ES8505956A1/es not_active Expired
- 1984-04-26 PT PT78493A patent/PT78493B/pt not_active IP Right Cessation
- 1984-04-26 EP EP84104704A patent/EP0124090B1/en not_active Expired
- 1984-04-26 HU HU841618A patent/HU191928B/hu not_active IP Right Cessation
- 1984-04-26 HU HU841619A patent/HU191753B/hu not_active IP Right Cessation
- 1984-04-26 NZ NZ207961A patent/NZ207961A/en unknown
- 1984-04-26 DE DE8484104703T patent/DE3462503D1/de not_active Expired
- 1984-04-26 IL IL71649A patent/IL71649A/xx unknown
- 1984-04-26 NZ NZ207960A patent/NZ207960A/en unknown
- 1984-04-26 AT AT84104704T patent/ATE26262T1/de not_active IP Right Cessation
- 1984-04-26 IL IL71648A patent/IL71648A/xx unknown
- 1984-04-26 PH PH30602A patent/PH20256A/en unknown
- 1984-04-26 DE DE8484104704T patent/DE3462889D1/de not_active Expired
- 1984-04-26 CA CA000452889A patent/CA1256880A/en not_active Expired
- 1984-04-26 EP EP84104703A patent/EP0124089B1/en not_active Expired
- 1984-04-26 AT AT84104703T patent/ATE25678T1/de active
- 1984-04-26 PT PT78491A patent/PT78491B/pt not_active IP Right Cessation
- 1984-04-26 CA CA000452888A patent/CA1242443A/en not_active Expired
- 1984-04-27 NO NO841690A patent/NO164416C/no unknown
- 1984-04-27 IE IE1046/84A patent/IE57273B1/en not_active IP Right Cessation
- 1984-04-27 IE IE1047/84A patent/IE57285B1/en not_active IP Right Cessation
- 1984-04-27 GR GR74536A patent/GR81967B/el unknown
- 1984-04-27 NO NO841691A patent/NO164415C/no unknown
- 1984-04-27 DD DD84262415A patent/DD223444A5/de not_active IP Right Cessation
- 1984-04-27 JP JP59084235A patent/JPS59206356A/ja active Granted
- 1984-04-27 GR GR74535A patent/GR81990B/el unknown
- 1984-04-27 DK DK213584A patent/DK159425C/da not_active IP Right Cessation
- 1984-04-27 JP JP59084234A patent/JPS59206355A/ja active Granted
- 1984-04-27 DK DK213284A patent/DK159424C/da not_active IP Right Cessation
- 1984-04-28 KR KR1019840002298A patent/KR900005011B1/ko not_active IP Right Cessation
- 1984-04-28 KR KR1019840002297A patent/KR900005010B1/ko not_active IP Right Cessation
- 1984-04-28 SU SU843732701A patent/SU1299505A3/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
NO158021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat. | |
NO161065C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner. | |
NO163691C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider. | |
NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
NO162858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater. | |
NO166320C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
NO156693C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider. | |
NO161679C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. | |
NO158183C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner. | |
NO167510C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer | |
NO158534C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater. | |
NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
NO164415C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
NO160000C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser. | |
NO158673C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. | |
NO163330C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater. | |
NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
NO161800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler. | |
NO164417C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater. | |
NO163529C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner. |